Study patients reported a 50% reduction in seizure severity as well as an improvement in mood among 49% of patients. Improvements in memory and achievement were seen in 38% and 39% of patient, respectively. Moreover, patients reported a 64% reduction in seizure worry.
This lightweight skin-adhesive diagnostic patch is able to record nasal pressure, blood oxygen saturation, pulse, respiratory effort, sleep time, and body position.
All 16 infants in the clinical trial of the device demonstrated a successful joining of their esophagus within 3-10 days after receiving it.
Abbott announced that the Food and Drug Administration (FDA) has approved the MRI-compatible Assurity MRI pacemaker, as well as the Tendril MRI pacing lead.
The FDA has received reports of serious adverse events which describe medication dosing inaccuracies and other mechanical problems with the pump that have led to patient injury and death.
ResMed announced that the Food and Drug Administration (FDA) granted clearance for ResMed AirMini, the smallest continuous positive airway pressure (CPAP) device for patients with sleep apnea.
Masimo announced that the Food and Drug Administration (FDA) has granted clearance for the TFA-1 Single-Patient-Use Adhesive Forehead Sensor that allows clinicians to monitor patients using Masimo SET Measure-through Motion and Low Perfusion pulse oximetry from the forehead instead of a finger.
A new study published in Advanced Materials reports on the development of a "smart" patch that can monitor a patient's blood and release blood thinners as needed to prevent the occurrence of thrombosis.
The Food and Drug Administration (FDA) has approved the marketing of the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and ImPACT Pediatric medical devices to assess a patient's cognitive function immediately after a suspected brain injury or concussion.
The FDA has approved an expanded indication for the Sapien XT and Sapien 3 transcatheter heart valves (Edwards Lifesciences) for patients with aortic valve stenosis who are at intermediate risk for death or complications associated with open-heart surgery.